Mealey's (January 19, 2021, 2:05 PM EST) -- WASHINGTON, D.C. — In a Jan. 15 judgment, the Federal Circuit U.S. Court of Appeals upheld a decision by the Patent Trial and Appeal Board to allow, on remand, substitute patent claims in an inter partes review (IPR), in a win for the owner of a patented treatment of prostate cancer....